CD274 and breast cancer: Studies have found that RES directly destroys the N-linked glycan modification and dimerization of PD-L1 in JIMT-1 breast cancer cells, inhibits the correct localization of glycosylated PD-L1 to the cell membrane, blocks the PD-1/PD-L1 axis between CTLs and cancer cells.